Non-Registered Director Shin Seung-won Acquires 600 Common Shares via Open Market (0.00% Stake)
- Non-registered director Shin Seung-won newly acquired 600 common shares (0.00% stake) of Samjin Pharmaceutical through open market purchases on May 14-15, 2026.
- Acquisition details: 50 shares (inherited, no cost), 2 shares at 17,830 won, and 548 shares at 17,860 won, totaling 600 shares.
ADVERTISEMENT (250px+)
KOSPI Filing Information
- Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
- Company: Samjin Pharmaceutical (005500)
- Submission: Shin Seung-won
- Receipt: 05-21-2026